
Ojas Pharmaceuticals Private Limited
About Ojas Pharmaceuticals Private Limited
Data last updated:
Ojas Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 November 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1993PTC016508. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹4.25 Cr and a paid-up capital of ₹93.45 Lakh. It was formerly known as Sangfroid Industries Limited. It is led by directors including Adisesha Giri Jagarapu and Shabarish Jagarapu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Ojas Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Sangfroid Industries Limited, and Ojas Pharmaceuticals Private Limited. The current legal name is Ojas Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Ojas Pharmaceuticals Private Limited | Current |
| Sangfroid Industries Limited | Previous |
CIN history
Ojas Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230TG1993PTC016508, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1993PTC016508 | Current |
| U24230AP1993PLC016508 | Previous |
| U24230TG1993PLC016508 | Previous |
Contact details
Ojas Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No 40A Road No 7, Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ojas Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ojas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ojas Pharmaceuticals Private Limited
Ojas Pharmaceuticals has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adisesha Giri Jagarapu Also directs: Hetero Drugs Limited, Honour Lab Limited | Director | 22 Jun 2020 | 6 Years 4 Months | Current |
| Shabarish Jagarapu | Director | 12 Mar 2017 | 9 Years 7 Months | Current |
| Shoba Devi Jagarapu Also directs: Degradable Polymer Technologies Private Limited | Director | 16 Jul 2021 | 5 Years 3 Months | Current |
Legal cases
Ojas Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Ojas Pharmaceuticals, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed against the company by Ms. Kotak Mahindra Bank Ltd., | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against individuals | Disposed |
| High Court, TELANGANA | Company petition | Filed by the company | Disposed |
To see the full case history of Ojas Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ojas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ojas Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ojas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ojas Pharmaceuticals Private Limited has 11 board changes on record since 2008: 3 appointments and 8 cessations. The latest: Basavaraju Murali Krishna ceased to be Director on 16 Jul 2021.
2 earlier events are in the company report.
Frequently asked questions
Ojas Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 November 1993 (33+ years old) and is registered under CIN U24230TG1993PTC016508.
Ojas Pharmaceuticals has 3 current directors:
- Adisesha Giri Jagarapu - Director
- Shabarish Jagarapu - Director
- Shoba Devi Jagarapu - Director
The latest financial statements of Ojas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Ojas Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Ojas Pharmaceuticals is U24230TG1993PTC016508. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ojas Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the high courts.
Ojas Pharmaceuticals was incorporated on 02 November 1993, making it 33+ years old. It is registered with the Registrar of Companies, Hyderabad.
Basavaraju Murali Krishna ceased to be Director on 16 Jul 2021. Shoba Devi Jagarapu was appointed as Director on 16 Jul 2021. Adisesha Giri Jagarapu ceased to be Additional Director on 30 Dec 2020. Ojas Pharmaceuticals has 11 board changes on record in total.
The registered office of Ojas Pharmaceuticals is at Plot No 40A Road No 7, Jubilee Hills, Hyderabad, Telangana, India – 500033.
Ojas Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

